アジア太平洋地域のオピオイド市場予測 2030 年 - 地域別分析 - 製品別 (即効性短時間作用型オピオイドと徐放性長時間作用型オピオイド)、用途別 (疼痛管理、麻酔、下痢抑制、咳抑制、依存症治療など)、投与経路別 (経口、注射、経皮パッチ)、流通チャネル別 (病院薬局、小売薬局)
慢性疼痛の発生率の急増により、アジア太平洋地域のオピオイド市場が拡大
心血管疾患、がん、筋骨格系疾患、神経血管疾患などの慢性疾患は、免疫力を低下させることで人の健康に重大な影響を及ぼします。さらに、これらの症状に苦しむ患者の多くは慢性疼痛を経験しています。上記の疾患は、成人および高齢者に最も多く見られます。しかし、これらの疾患の症例は子供の間でも著しく増加しています。慢性疼痛は、スポーツ選手、アスリート、過去の負傷を抱えて生活している人々にもよく見られます。 NCBI (国立生物工学情報センター) で発表された研究によると、世界中で成人の 20% が痛みに悩まされており、10% が毎年新たに慢性的な痛みと診断されています。痛みは性別、人種/民族、収入、年齢、地域に関係なく、すべての人口に影響を及ぼしますが、世界中で均等に分布しているわけではありません。ヒドロコドン、オキシコドン、モルヒネなどの処方オピオイドは、怪我、手術、がんや関節炎などの健康状態によって引き起こされる痛みの治療に使用される強力な鎮痛薬です。
オピオイドの処方が増えているのは、代替の鎮痛治療よりもオピオイドを奨励する保険償還プログラム、より効率的な治療を促すコスト構造、患者満足度と効果的な疼痛管理を組み合わせた評価によるものです。したがって、疼痛管理におけるオピオイドの利点により、慢性疾患の患者の間で需要が高まっています。
アジア太平洋地域のオピオイド市場概要
中国では、末期疾患に苦しむ老年人口が増加しており、オピオイドの需要が大幅に増加すると見込まれています。世界保健機関（WHO）によると、中国は高齢化が最も急速に進んでいる国の一つです。同じ情報源によると、2019年には2億5,400万人が60歳以上、1億7,600万人が65歳以上でした。また、平均寿命の延長と出生率の低下により、2040年までに中国の人口の約28％（4億200万人）が60歳以上になると予想されています。高齢者は、関節炎、腰痛、がんなど、痛みに関連する慢性的な健康状態を経験する可能性が高くなります。このような場合、オピオイドは高齢者の慢性的な痛みを管理するために使用され、これが中国のアジア太平洋地域のオピオイド市場の成長に大きな影響を与えます。中国では、重度の病的な痛みに苦しむ新しいがん患者の数が大幅に増加しています。 2020年に発表された研究「中国における医師の継続的医学教育が癌疼痛治療の質に与える影響」によると、中国政府は中等度から重度の癌疼痛の治療にオピオイド鎮痛剤の使用を奨励しており、全国の三次病院および二次病院で広く入手可能です。オピオイドは3段階鎮痛ラダーの主要部分であり、中等度から重度の癌疼痛の緩和に推奨されているため、このような病状と関連治療に関する認識を高めることで、癌疼痛の治療計画を改善できます。
アジア太平洋地域のオピオイド市場の収益と2030年までの予測（百万米ドル）
アジア太平洋地域のオピオイド市場のセグメンテーション
アジア太平洋地域のオピオイド市場は、製品、用途、投与経路、流通チャネル、および国に分類されています。
製品に基づいて、アジア太平洋地域のオピオイド市場は、即放性短時間作用型オピオイドと徐放性長時間作用型オピオイドに分かれています。即放性短時間作用型オピオイドセグメントは、2022年に大きな市場シェアを占めました。即放性短時間作用型オピオイドは、オキシコドン、ヒドロコドン、トラマドール、コジン、プロポキシフェンなどにさらに細分化されています。徐放性長時間作用型オピオイドは、オキシコドン、フェンタニル、モルヒネ、メタドンなどにさらに細分化されています。
用途別に見ると、アジア太平洋地域のオピオイド市場は、疼痛管理、麻酔、下痢抑制、咳抑制、依存症治療などに分類されています。 2022年には、疼痛管理セグメントが最大の市場シェアを占めました。
投与経路別に見ると、アジア太平洋地域のオピオイド市場は、経口、注射、経皮パッチに分類されます。経口セグメントは、2022年に最大の市場シェアを占めました。
流通チャネル別に見ると、アジア太平洋地域のオピオイド市場は、病院薬局と小売薬局に分かれています。病院薬局セグメントは、2022年に大きな市場シェアを占めました。
国別に見ると、アジア太平洋地域のオピオイド市場は、中国、日本、インド、韓国、オーストラリア、その他のアジア太平洋地域に分類されます。 2022年、アジア太平洋地域のオピオイド市場シェアは中国が独占しました。
アジア太平洋地域のオピオイド市場で事業を展開している大手企業には、Endo International plc、Mallinckrodt Plc、Neuraxpharm Pharmaceuticals SL、Mayne Pharma Group Ltd、Rusan Pharma Ltd、Teva Pharmaceutical Industries Ltdなどがあります。
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Opioids Market - Key Market Dynamics
4.1 Market Drivers
4.1.1 Surging Chronic Pain Incidence
4.1.2 Increasing Geriatric Population
4.2 Market Restraints
4.2.1 Increasing Drug Abuse
4.3 Market Opportunities
4.3.1 Strategic Initiatives by Market Players
4.4 Impact of Drivers and Restraints:
5. Opioids Market - Asia Pacific Analysis
5.1 Asia Pacific Opioids Market Overview
5.2 Asia Pacific Opioids Market Revenue (US$ Million), 2020-2030
5.3 Asia Pacific Opioids Market Forecast Analysis
6. Asia Pacific Opioids Market Analysis - by Product
6.1 Immediate Release Short Acting Opioid
6.1.1 Overview
6.1.2 Immediate Release Short Acting Opioid: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
6.1.2.1 Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
6.2 Extended Release Long-Acting Opioid
6.2.1 Overview
6.2.2 Extended Release Long-Acting Opioid: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
6.2.2.1 Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
7. Asia Pacific Opioids Market Analysis - by Application
7.1 Pain Management
7.1.1 Overview
7.1.2 Pain Management: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.2 Anesthesia
7.2.1 Overview
7.2.2 Anesthesia: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Diarrhea Suppression
7.3.1 Overview
7.3.2 Diarrhea Suppression: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Cough Suppression
7.4.1 Overview
7.4.2 Cough Suppression: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.5 De-Addiction
7.5.1 Overview
7.5.2 De-Addiction: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Opioids Market Analysis - by Route of Administration
8.1 Oral
8.1.1 Overview
8.1.2 Oral: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8.2 Injectable
8.2.1 Overview
8.2.2 Injectable: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Transdermal Patch
8.3.1 Overview
8.3.2 Transdermal Patch: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
9. Asia Pacific Opioids Market Analysis - by Distribution Channel
9.1 Hospital Pharmacies
9.1.1 Overview
9.1.2 Hospital Pharmacies: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
9.2 Retail Pharmacies
9.2.1 Overview
9.2.2 Retail Pharmacies: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10. Asia Pacific Opioids Market - Country Analysis
10.1 Asia Pacific
10.1.1 Asia Pacific: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
10.1.1.1 Asia Pacific: Opioids Market - Revenue and Forecast Analysis - by Country
10.1.1.2 China: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 China: Asia Pacific Opioids Market Breakdown, by Product
10.1.1.2.2 China: Asia Pacific Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.2.3 China: Asia Pacific Opioids Market Breakdown, by Extended Release Long-Acting Opioid
10.1.1.2.4 China: Asia Pacific Opioids Market Breakdown, by Application
10.1.1.2.5 China: Asia Pacific Opioids Market Breakdown, by Route of Administration
10.1.1.2.6 China: Asia Pacific Opioids Market Breakdown, by Distribution Channel
10.1.1.3 Japan: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Japan: Asia Pacific Opioids Market Breakdown, by Product
10.1.1.3.2 Japan: Asia Pacific Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.3.3 Japan: Asia Pacific Opioids Market Breakdown, by Extended Release Long-Acting Opioid
10.1.1.3.4 Japan: Asia Pacific Opioids Market Breakdown, by Application
10.1.1.3.5 Japan: Asia Pacific Opioids Market Breakdown, by Route of Administration
10.1.1.3.6 Japan: Asia Pacific Opioids Market Breakdown, by Distribution Channel
10.1.1.4 India: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.1 India: Asia Pacific Opioids Market Breakdown, by Product
10.1.1.4.2 India: Asia Pacific Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.4.3 India: Asia Pacific Opioids Market Breakdown, by Extended Release Long-Acting Opioid
10.1.1.4.4 India: Asia Pacific Opioids Market Breakdown, by Application
10.1.1.4.5 India: Asia Pacific Opioids Market Breakdown, by Route of Administration
10.1.1.4.6 India: Asia Pacific Opioids Market Breakdown, by Distribution Channel
10.1.1.5 South Korea: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.1 South Korea: Asia Pacific Opioids Market Breakdown, by Product
10.1.1.5.2 South Korea: Asia Pacific Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.5.3 South Korea: Asia Pacific Opioids Market Breakdown, by Extended Release Long-Acting Opioid
10.1.1.5.4 South Korea: Asia Pacific Opioids Market Breakdown, by Application
10.1.1.5.5 South Korea: Asia Pacific Opioids Market Breakdown, by Route of Administration
10.1.1.5.6 South Korea: Asia Pacific Opioids Market Breakdown, by Distribution Channel
10.1.1.6 Australia: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.1 Australia: Asia Pacific Opioids Market Breakdown, by Product
10.1.1.6.2 Australia: Asia Pacific Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.6.3 Australia: Asia Pacific Opioids Market Breakdown, by Extended Release Long-Acting Opioid
10.1.1.6.4 Australia: Asia Pacific Opioids Market Breakdown, by Application
10.1.1.6.5 Australia: Asia Pacific Opioids Market Breakdown, by Route of Administration
10.1.1.6.6 Australia: Asia Pacific Opioids Market Breakdown, by Distribution Channel
10.1.1.7 Rest of Asia Pacific: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.7.1 Rest of Asia Pacific: Asia Pacific Opioids Market Breakdown, by Product
10.1.1.7.2 Rest of Asia Pacific: Asia Pacific Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.7.3 Rest of Asia Pacific: Asia Pacific Opioids Market Breakdown, by Extended Release Long-Acting Opioid
10.1.1.7.4 Rest of Asia Pacific: Asia Pacific Opioids Market Breakdown, by Application
10.1.1.7.5 Rest of Asia Pacific: Asia Pacific Opioids Market Breakdown, by Route of Administration
10.1.1.7.6 Rest of Asia Pacific: Asia Pacific Opioids Market Breakdown, by Distribution Channel
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies in Opioids Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Endo International plc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Mallinckrodt Plc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Neuraxpharm Pharmaceuticals SL
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Mayne Pharma Group Ltd
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Rusan Pharma Ltd
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Teva Pharmaceutical Industries Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
?
List of Tables
Table 1. Asia Pacific Opioids Market Segmentation
Table 2. Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Table 3. Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 4. Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 5. Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 6. Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 7. Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 8. Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 9. Asia Pacific: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Country
Table 10. China: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 11. China: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 12. China: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 13. China: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 14. China: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 15. China: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 16. Japan: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 17. Japan: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 18. Japan: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 19. Japan: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 20. Japan: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 21. Japan: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 22. India: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 23. India: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 24. India: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 25. India: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 26. India: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 27. India: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 28. South Korea: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 29. South Korea: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 30. South Korea: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 31. South Korea: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 32. South Korea: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 33. South Korea: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 34. Australia: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 35. Australia: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 36. Australia: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 37. Australia: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 38. Australia: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 39. Australia: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 40. Rest of Asia Pacific: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 41. Rest of Asia Pacific: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 42. Rest of Asia Pacific: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 43. Rest of Asia Pacific: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 44. Rest of Asia Pacific: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 45. Rest of Asia Pacific: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 46. Recent Organic Growth Strategies in Opioids Market
Table 47. Recent Inorganic Growth Strategies in the Opioids Market
Table 48. Glossary of Terms, Opioids Market
?
List of Figures
Figure 1. Asia Pacific Opioids Market Segmentation, by Country
Figure 2. Asia Pacific Opioids Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Asia Pacific Opioids Market Revenue (US$ Million), 2020-2030
Figure 5. Asia Pacific Opioids Market Share (%) - by Product (2022 and 2030)
Figure 6. Immediate Release Short Acting Opioid: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Extended Release Long-Acting Opioid: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Asia Pacific Opioids Market Share (%) - by Application (2022 and 2030)
Figure 9. Pain Management: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Anesthesia: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Diarrhea Suppression: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Cough Suppression: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. De-Addiction: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Asia Pacific Opioids Market Share (%) - by Route of Administration (2022 and 2030)
Figure 16. Oral: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Injectable: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Transdermal Patch: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Asia Pacific Opioids Market Share (%) - by Distribution Channel (2022 and 2030)
Figure 20. Hospital Pharmacies: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Retail Pharmacies: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Asia Pacific: Opioids Market, by Key Countries - Revenue (2022) (US$ Million)
Figure 23. Asia Pacific: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 24. China: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Japan: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. India: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. South Korea: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Australia: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. Rest of Asia Pacific: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 30. Growth Strategies in Opioids Market
- Endo International plc
- Mallinckrodt Plc
- Neuraxpharm Pharmaceuticals SL
- Mayne Pharma Group Ltd
- Rusan Pharma Ltd
- Teva Pharmaceutical Industries Ltd
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific opioids market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific opioids market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific opioids market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.